Medicare Part D coverage · riluzole · RxCUI 2059266
riluzole 5 MG/ML Oral Suspension [Tiglutik]
Per the CMS 2026 Part D formulary file, riluzole 5 MG/ML Oral Suspension [Tiglutik] is covered by 106 Medicare Part D plans (2.1% of enrollable products), averaging Tier 3.2, with prior authorization required on 42.1% of covering formularies.
- 2.1%
- Plan coverage
- 106
- Plans covering
- T3.2
- Avg tier
- 42.1%
- Prior auth required
What the CMS Formulary Data Shows for riluzole 5 MG/ML Oral Suspension [Tiglutik]
Per the CMS 2026 Part D formulary file, riluzole 5 MG/ML Oral Suspension [Tiglutik] (RxNorm concept RXCUI 2059266, generic name riluzole) appears on 19 distinct formulary files spanning 106 Medicare Part D plan offerings - 2.1% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 5, with a cross-plan average of Tier 3.2.
Real-world access to riluzole 5 MG/ML Oral Suspension [Tiglutik] depends on utilization management as much as tier placement: 42.1% of covering formularies require prior authorization. 0% require step therapy. 5.3% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 9,582 Part D beneficiaries filled riluzole 5 MG/ML Oral Suspension [Tiglutik] in 2023, with total plan-and-beneficiary spending of $10,340,622 and an average per-beneficiary annual cost of $1,079.17. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry riluzole 5 MG/ML Oral Suspension [Tiglutik] today.
Coverage Details
- Formularies covering
- 19
- Plans covering
- 106
- Coverage rate
- 2.1%
- Tier range
- Tier 1 – Tier 5
- Average tier
- Tier 3, Preferred Brand
Restrictions
- Prior authorization required
- 42.1% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 5.3% of formularies
2023 Medicare Spending
- Beneficiaries
- 9,582
- Total spending
- $10,340,622
- Avg per beneficiary
- $1,079.17
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering riluzole 5 MG/ML Oral Suspension [Tiglutik]
100 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| Abilis Health Community (HMO I-SNP) | Signature Advantage, LLC | T1 | Yes | $0 | KY, TN |
| Arkansas Integrated Providers (AIP) Dual Advantage (HMO D-SNP) | Arkansas Superior Select, Inc. | T1 | Yes | $0 | AR |
| Mass General Brigham SCO (HMO D-SNP) | Mass General Brigham Health Plan, Inc | T1 | No | $0 | MA |
| Mass General Brigham One Care (HMO D-SNP) | Mass General Brigham Health Plan, Inc | T1 | No | $0 | MA |
| Texas Independence Health Plan, Inc. (HMO I-SNP) | Texas Independence Health Plan, Inc. | T1 | Yes | $4.80 | TX |
| Texas Independence Community Plan (HMO I-SNP) | Texas Independence Health Plan, Inc. | T1 | Yes | $4.80 | TX |
| Tribute Select (HMO-POS I-SNP) | Arkansas Superior Select, Inc. | T1 | Yes | $8.90 | AR |
| Valor Health Plan (HMO I-SNP) | TSG Guard, Inc. | T1 | Yes | $31.40 | OH |
| WV Senior Advantage (HMO I-SNP) | West Virginia Senior Advantage, Inc. | T1 | Yes | $32.70 | WV |
| Abilis Health (HMO I-SNP) | Signature Advantage, LLC | T1 | Yes | $35.90 | KY, TN |
| CommuniCare Advantage ISNP (HMO I-SNP) | OH CHS SNP Inc. | T1 | Yes | $38.40 | IN, MD, OH |
| CalOptima Health OneCare Complete (HMO D-SNP) | Orange County Health Authority | T2 | Yes | $0 | CA |
| HealthSun HealthAdvantage Plan (HMO) | Healthsun Health Plans, Inc. | T5 | No | $0 | FL |
| HealthSun MediMax (HMO) | Healthsun Health Plans, Inc. | T5 | No | $0 | FL |
| HealthSun HealthAdvantage Plan (HMO) | Healthsun Health Plans, Inc. | T5 | No | $0 | FL |
| HealthSun HealthAdvantage Plan (HMO) | Healthsun Health Plans, Inc. | T5 | No | $0 | FL |
| HealthSun MediSun Plus (HMO D-SNP) | Healthsun Health Plans, Inc. | T5 | No | $0 | FL |
| HealthSun HealthAdvantage Plus (HMO) | Healthsun Health Plans, Inc. | T5 | No | $0 | FL |
| HealthSun HealthAdvantage Plus (HMO) | Healthsun Health Plans, Inc. | T5 | No | $0 | FL |
| HealthSun MediSun Extra (HMO D-SNP) | Healthsun Health Plans, Inc. | T5 | No | $0 | FL |
Show the next 30 plans
| HealthSun HealthAdvantage Plus (HMO) | Healthsun Health Plans, Inc. | T5 | No | $0 | FL |
| HealthSun VitalCare (HMO C-SNP) | Healthsun Health Plans, Inc. | T5 | No | $0 | FL |
| HealthSun VitalCare (HMO C-SNP) | Healthsun Health Plans, Inc. | T5 | No | $0 | FL |
| HealthSun MediSun Full Dual Plus (HMO D-SNP) | Healthsun Health Plans, Inc. | T5 | No | $0 | FL |
| HealthSun MediSun Full Dual Extra (HMO D-SNP) | Healthsun Health Plans, Inc. | T5 | No | $0 | FL |
| Simply Complete (HMO D-SNP) | Simply Healthcare Plans, Inc. | T5 | No | $0 | FL |
| Simply More (HMO) | Simply Healthcare Plans, Inc. | T5 | No | $0 | FL |
| Simply Complete (HMO D-SNP) | Simply Healthcare Plans, Inc. | T5 | No | $0 | FL |
| Simply Level (HMO C-SNP) | Simply Healthcare Plans, Inc. | T5 | No | $0 | FL |
| Simply Level (HMO C-SNP) | Simply Healthcare Plans, Inc. | T5 | No | $0 | FL |
| Simply More (HMO) | Simply Healthcare Plans, Inc. | T5 | No | $0 | FL |
| Simply Level (HMO C-SNP) | Simply Healthcare Plans, Inc. | T5 | No | $0 | FL |
| Simply More (HMO) | Simply Healthcare Plans, Inc. | T5 | No | $0 | FL |
| Simply Level (HMO C-SNP) | Simply Healthcare Plans, Inc. | T5 | No | $0 | FL |
| Simply Complete (HMO D-SNP) | Simply Healthcare Plans, Inc. | T5 | No | $0 | FL |
| Simply More (HMO) | Simply Healthcare Plans, Inc. | T5 | No | $0 | FL |
| Simply More (HMO) | Simply Healthcare Plans, Inc. | T5 | No | $0 | FL |
| Simply Level (HMO C-SNP) | Simply Healthcare Plans, Inc. | T5 | No | $0 | FL |
| Simply Complete (HMO D-SNP) | Simply Healthcare Plans, Inc. | T5 | No | $0 | FL |
| Simply More (HMO) | Simply Healthcare Plans, Inc. | T5 | No | $0 | FL |
| Simply Extra (HMO) | Simply Healthcare Plans, Inc. | T5 | No | $0 | FL |
| Simply Extra Platinum (HMO) | Simply Healthcare Plans, Inc. | T5 | No | $0 | FL |
| Simply More Platinum (HMO) | Simply Healthcare Plans, Inc. | T5 | No | $0 | FL |
| Simply Complete Platinum (HMO D-SNP) | Simply Healthcare Plans, Inc. | T5 | No | $0 | FL |
| Simply Level Platinum (HMO C-SNP) | Simply Healthcare Plans, Inc. | T5 | No | $0 | FL |
| Simply Extra Platinum (HMO) | Simply Healthcare Plans, Inc. | T5 | No | $0 | FL |
| Simply Level Platinum (HMO C-SNP) | Simply Healthcare Plans, Inc. | T5 | No | $0 | FL |
| Simply Extra Platinum (HMO) | Simply Healthcare Plans, Inc. | T5 | No | $0 | FL |
| Simply Level Platinum (HMO C-SNP) | Simply Healthcare Plans, Inc. | T5 | No | $0 | FL |
| Simply Extra Platinum (HMO) | Simply Healthcare Plans, Inc. | T5 | No | $0 | FL |
Showing top 50 of 100 plans.
Frequently Asked Questions
Is riluzole 5 MG/ML Oral Suspension [Tiglutik] covered by Medicare Part D?
Yes, riluzole 5 MG/ML Oral Suspension [Tiglutik] is covered by 106 Medicare Part D plans (2.1% of all Part D formularies).
What tier is riluzole 5 MG/ML Oral Suspension [Tiglutik] on Medicare Part D plans?
riluzole 5 MG/ML Oral Suspension [Tiglutik] averages Tier 3.2 across Part D plans, ranging from Tier 1 to Tier 5.
Does riluzole 5 MG/ML Oral Suspension [Tiglutik] require prior authorization?
42.1% of Part D formularies require prior authorization for riluzole 5 MG/ML Oral Suspension [Tiglutik]. Step therapy: 0%. Quantity limits: 5.3%.
How much does Medicare spend on riluzole 5 MG/ML Oral Suspension [Tiglutik]?
In 2023, total Medicare Part D spending on riluzole 5 MG/ML Oral Suspension [Tiglutik] was $10,340,622, covering 9,582 beneficiaries. The average spend per beneficiary was $1,079.17.
Read our methodology - how this data is sourced, computed, and verified.
Nationwide similar Part D drugs
Data-derived peers across the CMS Part D formulary extract: nearest average tier placement and nearest prior-authorization rate. Not therapeutic alternatives or same-generic strengths.
Closest average formulary tier
- leuprolide acetate 5 MG/ML Injectable Solution T3.2
- prednisone 5 MG/ML Oral Solution T3.2
- tazarotene 0.001 MG/MG Topical Gel T3.2
- 1 ML hydromorphone hydrochloride 10 MG/ML Injection T3.2
- 24 HR hydromorphone hydrochloride 32 MG Extended Release Oral Tablet T3.2
- dexlansoprazole 30 MG Delayed Release Oral Capsule T3.2
Similar prior-authorization rate
- anidulafungin 50 MG Injection [Eraxis] 42.1% PA
- dipyridamole 50 MG Oral Tablet 42.2% PA
- dipyridamole 75 MG Oral Tablet 42.2% PA
- dicyclomine hydrochloride 2 MG/ML Oral Solution 42.3% PA
- isotretinoin 30 MG Oral Capsule [Claravis] 41.9% PA
- isotretinoin 10 MG Oral Capsule [Claravis] 41.8% PA